Quick Answer
Dogwood Therapeutics, Inc. reported Total Assets of $90.17 million for fiscal year 2025.
Dogwood Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $90.17M | -4.4% |
| 2024 | $94.31M | +2164.1% |
| 2023 | $4.17M | -50.2% |
| 2022 | $8.37M | -46.9% |
| 2021 | $15.78M | -49.9% |
| 2020 | $31.47M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $91.99M | +3929.0% | -4.9% |
| June 30, 2025 | $96.69M | +2559.4% | -0.3% |
| March 31, 2025 | $96.98M | +2907.6% | +2.8% |
| December 31, 2024 | $94.31M | +2164.1% | +4030.4% |
| September 30, 2024 | $2.28M | -56.5% | -37.2% |
| June 30, 2024 | $3.64M | -30.2% | +12.8% |
| March 31, 2024 | $3.22M | -50.5% | -22.6% |
| December 31, 2023 | $4.17M | -50.2% | -20.6% |
- Dogwood Therapeutics, Inc. showed a decrease of -4.4% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Dogwood Therapeutics, Inc.’s total assets has grown by 186.5% (from $31.47 million to $90.17 million).
- The most recent figure is from Dogwood Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: